Allum W et al (2018) ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Crit Rev Oncol Hematol 122:179–193. https://doi.org/10.1016/j.critrevonc.2017.12.019

Article  PubMed  Google Scholar 

Anderson KJ, Cormier RT, Scott PM (2019) Role of ion channels in gastrointestinal cancer. World J Gastroenterol 25:5732–5772. https://doi.org/10.3748/wjg.v25.i38.5732

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bin YL et al (2021) Metabolic reprogramming in gastric Cancer. Trojan Horse Effect Front Oncol 11:745209. https://doi.org/10.3389/fonc.2021.745209

Article  CAS  PubMed  Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA. Cancer J Clin 74:229–263. https://doi.org/10.3322/caac.21834

Article  Google Scholar 

Brocke KS et al (2010) Glutamate receptors in pediatric tumors of the central nervous system. Cancer Biol Ther 9:455–468. https://doi.org/10.4161/cbt.9.6.10898

Article  CAS  PubMed  Google Scholar 

Chen P, Qian XK, Zhang YF, Sun XG, Shi XJ, Gao YS (2020) KLF5 promotes proliferation in gastric cancer via regulating p21 and CDK4. Eur Rev Med Pharmacol Sci 24:4224–4231. https://doi.org/10.26355/eurrev_202004_21002

Article  CAS  PubMed  Google Scholar 

Chen Z, Song Y, Li P, Gao W (2023) GRIN2D knockdown suppresses the progression of lung adenocarcinoma by regulating the E2F signalling. Pathw Cell Signal 107:110685. https://doi.org/10.1016/j.cellsig.2023.110685

Article  CAS  Google Scholar 

Cook ME, Jarjour NN, Lin CC, Edelson BT (2020) Transcription factor Bhlhe40 in immunity and autoimmunity. Trends Immunol 41:1023–1036. https://doi.org/10.1016/j.it.2020.09.002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferguson HJ, Wragg JW, Ward S, Heath VL, Ismail T, Bicknell R (2016) Glutamate dependent NMDA receptor 2D is a novel angiogenic tumour endothelial marker in colorectal. cancer Oncotarget 7:20440–20454. https://doi.org/10.18632/oncotarget.7812

Article  PubMed  Google Scholar 

Fernandez-Vizarra E, Zeviani M (2021) Mitochondrial disorders of the OXPHOS system. FEBS Lett 595:1062–1106. https://doi.org/10.1002/1873-3468.13995

Article  CAS  PubMed  Google Scholar 

Ganapathy-Kanniappan S, Geschwind JF (2013) Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer 12:152. https://doi.org/10.1186/1476-4598-12-152

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hashimoto I, Oshima T (2022) Claudins and gastric Cancer: an overview cancers (Basel). 14. https://doi.org/10.3390/cancers14020290

He Y, Wang Y, Luan F, Yu Z, Feng H, Chen B, Chen W (2021) Chinese and global burdens of gastric cancer from 1990 to 2019. Cancer Med 10:3461–3473. https://doi.org/10.1002/cam4.3892

Article  PubMed  PubMed Central  Google Scholar 

Huang G, Cai G, Hu D, Li J, Xu Q, Chen Z, Xu B (2022) Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition cell oncol. (Dordr) 45:1329–1346. https://doi.org/10.1007/s13402-022-00722-4

Article  CAS  Google Scholar 

Ji Z et al (2021) C-Myc-activated long non-coding RNA LINC01050 promotes gastric cancer growth and metastasis by sponging mir-7161-3p to regulate SPZ1 expression. J Exp Clin Cancer Res 40:351. https://doi.org/10.1186/s13046-021-02155-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia YF et al (2013) Differentiated embryonic chondrocyte-expressed gene 1 is associated with hypoxia-inducible factor 1alpha and Ki67 in human gastric cancer. Diagn Pathol 8:37. https://doi.org/10.1186/1746-1596-8-37

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia Y et al (2022) DEC1 promotes progression of Helicobacter pylori-positive gastric cancer by regulating Akt/NF-kappaB pathway. J Cell Mol Med 26:1943–1954. https://doi.org/10.1111/jcmm.17219

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kishi S et al (2021) Role of Glycated High Mobility Group Box-1 in gastric Cancer. Int J Mol Sci 22. https://doi.org/10.3390/ijms22105185

Li G, Zhang Z, Chen Z, Liu B, Wu H (2021) LncRNA DLEU2 is activated by STAT1 and induces gastric cancer development via targeting miR-23b-3p/NOTCH2 axis and notch signaling. Pathw Life Sci 277:119419. https://doi.org/10.1016/j.lfs.2021.119419

Article  CAS  Google Scholar 

Liu Y, Zhang Z, Wang J, Chen C, Tang X, Zhu J, Liu J (2019) Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review. Onco Targets Ther 12:1195–1204. https://doi.org/10.2147/OTT.S189687

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Yuan Q, Guo H, Guan H, Hong Z, Shang D (2024) Deciphering drug resistance in gastric cancer: potential mechanisms and future perspectives. Biomed Pharmacother 173:116310. https://doi.org/10.1016/j.biopha.2024.116310

Article  CAS  PubMed  Google Scholar 

Ma P et al (2020) KLF5-Modulated lncRNA NEAT1 contributes to Tumorigenesis by acting as a Scaffold for BRG1 to silence GADD45A in gastric Cancer Mol. Ther Nucleic Acids 22:382–395. https://doi.org/10.1016/j.omtn.2020.09.003

Article  CAS  PubMed  Google Scholar 

Peng Y et al (2012) Down regulation of differentiated embryonic chondrocytes 1 (DEC1) is involved in 8-methoxypsoralen-induced apoptosis in HepG2. Cells Toxicol 301:58–65. https://doi.org/10.1016/j.tox.2012.06.022

Article  CAS  Google Scholar 

Pouyssegur J, Marchiq I, Parks SK, Durivault J, Zdralevic M, Vucetic M (2022) Warburg effect’ controls tumor growth, bacterial, viral infections and immunity - genetic deconstruction and therapeutic perspectives. Semin Cancer Biol 86:334–346. https://doi.org/10.1016/j.semcancer.2022.07.004

Article  CAS  PubMed  Google Scholar 

Salmon AJ et al (2022) BHLHE40 regulates the T-Cell effector function required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy. Cancer Immunol Res 10:597–611. https://doi.org/10.1158/2326-6066.CIR-21-0129

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarg NH, Zaher DM, Abu Jayab NN, Mostafa SH, Ismail HH, Omar HA (2024) The interplay of p38 MAPK signaling and mitochondrial metabolism. Dynamic Target cancer Pathological Contexts Biochem Pharmacol 225:116307. https://doi.org/10.1016/j.bcp.2024.116307

Article  CAS  PubMed  Google Scholar 

Sato F, Bhawal UK, Yoshimura T, Muragaki Y (2016) DEC1 and DEC2 crosstalk between Circadian Rhythm and Tumor. Progression J Cancer 7:153–159. https://doi.org/10.7150/jca.13748

Article  CAS  PubMed  Google Scholar 

Schmidt CA, Fisher-Wellman KH, Neufer PD (2021) From OCR and ECAR to energy: perspectives on the design and interpretation of bioenergetics studies. J Biol Chem 297:101140. https://doi.org/10.1016/j.jbc.2021.101140

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sethuraman A, Brown M, Krutilina R, Wu ZH, Seagroves TN, Pfeffer LM, Fan M (2018) BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion. Breast Cancer Res 20:117. https://doi.org/10.1186/s13058-018-1046-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi DB, Wang YW, Xing AY, Gao JW, Zhang H, Guo XY, Gao P (2015) C/EBPalpha-induced miR-100 expression suppresses tumor metastasis and growth by targeting ZBTB7A in gastric cancer. Cancer Lett 369:376–385. https://doi.org/10.1016/j.canlet.2015.08.029